Namenda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
Conditions:   Cognitive Decline;   Chemo-brain Intervention:   Drug: Memantine Sponsors:   University of North Carolina, Chapel Hill;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2019 Category: Research Source Type: clinical trials